Recommendations of the Brazilian Society of Endocrinology and Metabology (SBEM) for the diagnosis and treatment of hypovitaminosis D;Recomendações da Sociedade Brasileira de Endocrinologia e Metabologia (SBEM) para o diagnóstico e tratamento da hipovitaminose D

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 58, Issue 5, 2014, Pages 411-433

  Maeda, Sergio Setsuo ^a   Borba, Victoria Z C ^b   Camargo, Marília Brasilio Rodrigues ^a   Silva, Dalisbor Marcelo Weber ^c   Borges, João Lindolfo Cunha ^d   Bandeira, Francisco ^e   Lazaretti Castro, Marise ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^c UNIVERSITY OF JOINVILLE REGION   (Brazil)

^d UNIVERSIDADE CATÓLICA DE BRASÍLIA   (Brazil)

^e FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Cholecalciferol; Deficiency; Diagnosis; Insufficiency; Osteoporosis; PTH; Treatment; Vitamin d

Indexed keywords

CALCIFEDIOL; CALCIUM INTAKE; COLECALCIFEROL; ERGOCALCIFEROL; PARATHYROID HORMONE;

ADVERSE EFFECTS; BARIATRIC SURGERY; BIBLIOGRAPHIC DATABASE; BLOOD; BRAZIL; CALCIUM INTAKE; CONSENSUS DEVELOPMENT; DIET THERAPY; EVIDENCE BASED MEDICINE; FRAGILITY FRACTURE; HUMAN; HYPERPARATHYROIDISM; MALABSORPTION SYNDROMES; OSTEOPOROSIS; PRACTICE GUIDELINE; RISK FACTOR; STANDARDS; THERAPEUTIC USE; VITAMIN D DEFICIENCY;

BARIATRIC SURGERY; BRAZIL; CALCIFEDIOL; CALCIUM, DIETARY; CHOLECALCIFEROL; DATABASES, BIBLIOGRAPHIC; ERGOCALCIFEROLS; EVIDENCE-BASED MEDICINE; HUMANS; HYPERPARATHYROIDISM; MALABSORPTION SYNDROMES; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; PARATHYROID HORMONE; RISK FACTORS; VITAMIN D DEFICIENCY;

EID: 84906672476     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/0004-2730000003388     Document Type: Article

References (166)

1. Mithal A, Wahl DA, Bonjour J P, Burckhardt P, Dawson-Hughes B, Eisman JA, et al.; IOF Committee of Scientifc Advisors (CSA) Nutrition Working Group. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int. 2009;20(11):1807-20.
2. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001;22(4):477-501.
3. Holick M F. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-281.
4. Levels of evidence and Grades of Recommendations - Oxford Centre for Evidence-Based Medicine. Available at: http://www.cebm.net/index.aspx?o=1025.
5. Programa Diretrizes. Associação Médica Brasileira. Available at: http://www.projetodiretrizes.amb.org.br.
6. Norman AW, Bouillon R. Vitamin D nutritional policy needs a vision for the future. Exp Biol Med (Maywood). 2010;235(9):1034-45.
7. Wacker M, Holick M F. Vitamin D - Effects on skeletal and ex-traskeletal health and the need for supplementation. Nutrients. 2013;5(1):111-48.
8. Holick M F. Vitamin D: evolutionary, physiological and health perspectives. Curr Drug Targets. 2011;12(1):4-18.
9. Holick M F, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87:1080S-6S.
10. McDonnell D P, Pike JW, O'Malley BW. The vitamin D receptor: a primitive steroid receptor related to thyroid hormone receptor. J Steroid Biochem. 1988;30(1-6):41-6.
11. Walters MR. Newly identifed actions of the vitamin D endocrine system. Endocr Rev. 1992;13(4):719-64.
12. Vieth R, Ladak Y, Walfsh PG. Age-related changes in the 25-hydro-xyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. J Clin Endocrinol Metab. 2003;88(1):185-91.
13. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Lu-derer H F, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008;29(6):726-76.
14. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol. 2005;289(1):F8-28.
15. Prestwood KM, Pannullo AM, Kenny AM, Pilbeam CC, Raisz LG. The effect of a short course of calcium and vitamin D on bone turnover in older women. Osteoporos Int. 1996;6:314-9.
16. Kamel S, Brazier M, Rogez JC, Vincent O, Maamer M, Desmet G, et al. Different responses of free and peptide-bound cross-links to vitamin D and calcium supplementation in elderly women with vitamin D insufficiency J Clin Endocrinol Metab. 1996;81(10):3717-21.
17. Cranney A, Weiler HA, O'Donnell S, Puil L. Summary of evidence-based review on vitamin D effcacy and safety in relation to bone health. Am J Clin Nutr. 2008;88(2):513S-9S.
18. McKenna MJ. Differences in vitamin D status between countries in young adults and the elderly. Am J Med. 1992;93:69-77.
19. van der Wielen R P, Löwik MR, van den Berg H, de Groot LC, Haller J, Moreiras O, et al. Serum vitamin D concentration among elderly people in Europe. Lancet. 1995;346(8969):207-10.
20. Chapuy MC, Pamphile R, Paris E, Kempf C, Schlichting M, Arnaud S, et al. Combined calcium and vitamin D3 supplementation in elderly women: confrmation of reversal of secondary hyperpara-thyroidism and hip fracture risk: The Decalyos II Study. Osteropo-ros Int. 2002;13:257-64.
21. Freaney R, McBrinn Y, McKenna MJ. Secondary hyperparathyroi-dism in elderly people: combined effect of renal insufficiency and vitamin D deficiency. Am J Clin Nutr. 1993;58:187-91.
22. Souberbielle JC, Cormier C, Kindermans C, Gao P, Cantor T, Fo-rette F, et al. Vitamin D status and redefning serum parathyoid hormone reference range in the elderly. J Clin Endocrinol Metab. 2001;86(7):3086-90.
23. McKenna MJ, Freaney R. Secondary hyperparathyroidism in the elderly: means to defning hypovitaminosis D. Osteoporos Int. 1998;8 Suppl 2:S3-6.
24. Cunningham J, Locatelli F, Rodriguez M. Secondary hyperpara-thyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol. 2011;6(4):913-21.
25. Fleet JC, Schoch RD. Molecular mechanisms for regulation of intestinal calcium absorption by vitamin D and other factors. Crit Rev Clin Lab Sci. 2010;47(4):181-95.
26. Heaney R P, Dowell MS, Hale CA, Bendich A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr. 2003;22(2):142-6.
27. Aloia J F, Dhaliwal R, Shieh A, Mikhail M, Fazzari M, Ragolia L, et al. Vitamin D supplementation increases calcium absorption without a threshold effect. Am J Clin Nutr. 2014;99(3):624-31.
28. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med. 2004;116(9):634-9.
29. Kuchuk NO, Pluijm SM, van Schoor NM, Looman CW, Smit JH, Lips P. Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J Clin Endocrinol Metab. 2009;94(4):1244-50.
30. Kuchuk NO, van Schoor NM, Pluijm SM, Chines A, Lips P. Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective. J Bone Miner Res. 2009;24(4):693-701.
31. Dhesi JK, Bearne LM, Moniz C, Hurley MV, Jackson SH, Swift CG, et al. Neuromuscular and psychomotor function in elderly subjects who fall and the relationship with vitamin D status. J Bone Miner Res. 2002;17(5):891-7.
32. Bischoff HA, Stähelin HB, Dick W, Akos R, Knecht M, Salis C, et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res. 2003;18(2):343-51.
33. Janssen HC, Samson MM, Verhaar HJ. Vitamin D deficiency, muscle function, and falls in elderly people. Am J Clin Nutr. 2002;75(4):611-5.
34. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA. 2005;293(18):2257-64.
35. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ. 2009;339:b3692.
36. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Daw-son-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84(1):18-28.
37. Bikle DD. Vitamin D and bone. Curr Osteoporos Rep. 2012;10(2):151-9.
38. Priemel M, von Domarus C, Klatte TO, Kessler S, Schlie J, Meier S, et al. Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res. 2010;25(2):305-12.
39. de Paula FJA, Rosen CJ. Vitamin D safety and requirements. Arch Biochem Biophys. 2012;523(1):64-72.
40. Bolland MJ, Grey A, Gamble GD, Reid IR. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol. 2014;2(4):307-20.
41. Holick M F, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney R P, et al.; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-30.
42. Heaney R P. What is vitamin D insufficiency? And does it matter? Calcify Tissue Int. 2013;92(2):177-83.
43. Heaney R P, Holick M F. Why the IOM recommendations for vitamin D are defcient. J Bone Miner Res. 2011;26(3):455-7.
44. Chapuy M-C, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int. 1997;7(5):439-43.
45. Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D suffciency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr. 2005;135(2):317-22.
46. Dawson-Hughes B, Heaney R P, Holick M F, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int. 2005;16(7):713-6.
47. Silva BCC, Camargos BM, Fujii JB, Dias E P, Soares MMS. Prevalence of vitamin D deficiency and its correlation with PTH, biochemical bone turnover markers and bone mineral density, among patients from ambulatories. Arq Bras Endocrinol Metabol. 2008;52(3):482-8.
48. Vieth R, Bischoff-Ferrari H, Boucher BJ, Dawson-Hughes B, Garland C F, Heaney R P, et al. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr. 2007;85(3):649-50.
49. Holick M F, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney R P, et al. Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab. 2012;97(4):1153-8.
50. Institute of Medicine (IOM). Dietary Reference Intakes (DRIs) for calcium and vitamin D. Report at a glance 2011. Available at: http://www.iom.edu/Reports/2010/Dietary-Reference-Intakes-for--Calcium-a nd-Vitamin-D/DRI-Values.aspx.
51. Lai JK, Lucas RM, Clements MS, Harrison SL, Banks E. Assessing vitamin D status: pitfalls for the unwary. Mol Nutr Food Res. 2010;54(8):1062-71.
52. El-Khoury JM, Reineks EZ, Wang S. Progress of liquid chromato-graphy-mass spectrometry in measurement of vitamin D metabolites and analogues. Clin Biochem. 2011;44(1):66-76.
53. Ong L, Saw S, Sahabdeen NB, Tey K T, Ho CS, Sethi SK. Current 25 hydroxyvitamin D assays: do they pass the test? Clin Chim Acta. 2012;413(13-14):1127-34.
54. Binkley N, Wiebe D. Clinical controversies in vitamin D: 25(OH)D measurement, target concentration, and supplementation. J Clin Densitom. 2013;16(4):402-8.
55. Carter GD, Berry JL, Gunter E, Jones G, Jones JC, Makin HL, et al. Profciency testing of 25-hydroxyvitamin D (25-OHD) assays. J Steroid Biochem Mol Biol. 2010;121(1-2):176-9.
56. Barake M, Daher RT, Salti I, Cortas NK, Al-Shaar L, Habib RH, et al. 25-hydroxyvitamin D assay variations and impact on clinical decision making. J Clin Endocrinol Metab. 2012;97(3):835-43.
57. Singh DK, Farrington K, Twomey PJ. Analytical quality goals for 25-vitamin D based on biological variation. J Clin Lab Anal. 2011;25(2):130-3.
58. Powe CE, Karumanchi SA, Thadhani R. Vitamin D-binding protein and vitamin D in blacks and whites. N Engl J Med. 2014;370(9):880-1.
59. McDuffe JR, Calis KA, Booth SL, Uwaifo GI, Yanovski JA. Effects of orlistat on fat-soluble vitamins in obese adolescents. Pharma-cotherapy. 2002;22(7):814-22.
60. Reichrath J, Nürnberg B. Cutaneous vitamin D synthesis versus skin cancer development: The Janus faces of solar UV-radiation. Dermatoendocrinol. 2009;1(5):253-61.
61. Jamali Z, Asadikaram G, Mahmoodi M, Sayadi A, Jamalizadeh A, Saleh-Moghadam M, et al. Vitamin D status in female students and its relation to calcium metabolism markers, lifestyles, and polymorphism in vitamin D receptor. Clin Lab. 2013;59(3-4):407-13.
62. Allali F, El Aichaoui S, Khazani H, Benyahia B, Saoud B, El Kabbaj S, et al. High prevalence of hypovitaminosis D in Morocco: relationship to lifestyle, physical performance, bone markers, and bone mineral density. Semin Arthritis Rheum. 2009;38(6):444-51.
63. Gannagé-Yared MH, Chemali R, Yaacoub N, Halaby G. Hypovita-minosis D in a sunny country: relation to lifestyle and bone markers. J Bone Miner Res. 2000;15(9):1856-62.
64. Peters BSE, dos Santos LC, Fisberg M, Wood RJ, Martini LA. Prevalence of vitamin D insufficiency in Brazilian adolescents. Ann Nutr Metab. 2009;54(1):15-21.
65. Oliveira RM, Novaes J F, Azeredo LM, Cândido A P, Leite IC. Association of vitamin D insufficiency with adiposity and metabolic disorders in Brazilian adolescents. Public Health Nutr. 2013;9:1-8.
66. Santos BR, Mascarenhas L P, Satler F, Boguszewski MC, Spritzer PM. Vitamin D deficiency in girls from South Brazil: a cross-sectional study on prevalence and association with vitamin D receptor gene variants. BMC Pediatr. 2012;12:62.
67. Unger MD, Cuppari L, Titan SM, Magalhães MC, Sassaki AL, dos Reis LM, et al. Vitamin D status in a sunny country: where has the sun gone? Clin Nutr. 2010;29(6):784-8.
68. Maeda SS, Kunii IS, Hayashi L, Lazaretti-Castro M. The effect of sun exposure on 25-hydroxyvitamin D concentrations in young healthy subjects living in the city of São Paulo, Brazil. Braz J Med Biol Res. 2007;40(12):1653-9.
69. Maeda SS, Saraiva GL, Kunii IS, Hayashi L F, Cendoroglo MS, Ramos LR, et al. Factors affecting vitamin D status in different populations in the city of São Paulo, Brazil: the São PAulo vitamin D Evaluation Study (SPADES). BMC Endocr Disord. 2013;13(1):14.
70. Saraiva GL, Cendoroglo MS, Ramos LR, Araújo LM, Vieira JG, Maeda SS, et al. Prevalence of vitamin D deficiency, insufficiency and secondary hyperparathyroidism in the elderly inpatients and living in the community of the city of São Paulo, Brazil. Arq Bras Endocrinol Metabol. 2007;51(3):437-42.
71. Maeda SS, Kunii IS, Hayashi L F, Lazaretti-Castro M. Increases in summer serum 25-hydroxyvitamin D (25OHD) concentrations in elderly subjects in São Paulo, Brazil vary with age, gender and ethnicity. BMC Endocr Disord. 2010;10:12.
72. Silva BCC, Camargos BM, Fujii JB, Dias E P, Soares MMS. Prevalence of vitamin D deficiency and its correlation with PTH, biochemical bone turnover markers and bone mineral density, among patients from ambulatories. Arq Bras Endocrinol Metabol. 2008;52(3):482-8.
73. Saraiva GL, Cendoroglo MS, Ramos LR, Araújo LMQ, Vieira JGH, Kunii I, et al. Infuence of ultraviolet radiation on the production of 25 hydroxyvitamin D in the elderly population in the city of São Paulo (23° 34'S), Brazil. Osteoporos Int. 2005;16(12):1649-54.
74. Bandeira F, Griz L, Freese E, Lima DC, Thé AC, Diniz E T, et al. Vitamin D deficiency and its relationship with bone mineral density among postmenopausal women living in the tropics. Arq Bras Endocrinol Metabol. 2010;54(2):227-32.
75. Neves J P, Silva AS, Morais LC, Diniz Ada S, Costa MJ, Asciutti LS, et al. 25-hydroxyvitamin D concentrations and blood pressure levels in hypertensive elderly patients. Arq Bras Endocrinol Meta-bol. 2012;56(7):415-22.
76. Arantes H P, Kulak CA, Fernandes CE, Zerbini C, Bandeira F, Barbo-sa IC, et al. Correlation between 25-hydroxyvitamin D levels and latitude in Brazilian postmenopausal women: from the Arzoxife-ne Generations Trial. Osteoporos Int. 2013;24(10):2707-12.
77. Russo LA, Gregório LH, Lacativa PG, Marinheiro L P. Concentration of 25-hydroxyvitamin D in postmenopausal women with low bone mineral density. Arq Bras Endocrinol Metabol. 2009;53(9):1079-87.
78. Lips P, Hosking D, Lippuner K, Norquist JM, Wehren L, Maalouf G, et al. The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Int Med. 2006;260(3):245-54
79. Kuchuk NO, van Schoor NM, Pluijm SM, Chines A, Lips P. Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective. J Intern Med. 2006;260(3):245-54.
80. Lopes JB, Danilevicius C F, Takayama L, Caparbo V F, Scazufca M, Bonfá E, et al. Vitamin D insufficiency: a risk factor to vertebral fractures in community-dwelling elderly women. Maturitas. 2009;64(4):218-22.
81. Martini LA, Verly E Jr, Marchioni DM, Fisberg RM. Prevalence and correlates of calcium and vitamin D status adequacy in adolescents, adults, and elderly from the Health Survey-São Paulo. Nutrition. 2013;29(6):845-50.
82. Cabral MA, Borges CN, Maia JM, Aires CA, Bandeira F. Prevalence of vitamin D deficiency during the summer and its relationship with sun exposure and skin phototype in elderly men living in the tropics. Clin Interv Aging. 2013;8:1347-51.
83. Binkley N, Gemar D, Engelke J, Gangnon R, Ramamurthy R, Krue-ger D, et al. Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults. J Clin Endo-crinol Metab. 2011;96(4):981-8.
84. Aloia J F, Chen DG, Yeh JK, Chen H. Serum vitamin D metabolites and intestinal calcium absorption effciency in women. Am Am J Clin Nutr. 2010;92(4):835-40.
85. Nordin BE. Evolution of the calcium paradigm: the relation between vitamin D, serum calcium and calcium absorption. Nutrients. 2010;2(9):997-1004.
86. Bischoff-Ferrari HA, Willett WC, Orav EJ, Lips P, Meunier PJ, Lyons RA, et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med. 2012;367(1):40-9.
87. Canto-Costa MH, Kunii I, Hauache OM. Body fat and cholecalciferol supplementation in elderly homebound individuals. Braz J Med Biol Res. 2006;39(1):91-8.
88. Moreira-Pfrimer LD, Pedrosa MA, Teixeira L, Lazaretti-Castro M. Treatment of vitamin D deficiency increases lower limb muscle strength in institutionalized older people independently of regular physical activity: a randomized double-blind controlled trial. Ann Nutr Metab. 2009;54(4):291-300.
89. Mocanu V, Stitt PA, Costan AR, Voroniuc O, Zbranca E, Luca V, et al. Long-term effects of giving nursing home residents bread for-tifed with 125 microg (5000 IU) vitamin D(3) per daily serving. Am J Clin Nutr. 2009;89(4):1132-7.
90. Mocanu V, Vieth R. Three-year follow-up of serum 25-hydroxyvi-tamin D, parathyroid hormone, and bone mineral density in nursing home residents who had received 12 months of daily bread fortifcation with 125 μg of vitamin D3. Nutr J. 2013;12:137.
91. Camargo MBR. Fatores determinantes do status de vitamina D em pacientes de um ambulatório especializado em osteoporose e sua interferência sobre a absorção de cálcio [tese]. São Paulo: Universidade Federal de São Paulo; 2013.
92. Winzenberg T, Powell S, Shaw KA, Jones G. Effects of vitamin D supplementation on bone density in healthy children: systematic review and meta-analysis. BMJ. 2011;342:c7254.
93. Vieth R. Implications for 25-hydroxyvitamin D testing of public health policies about the benefts and risks of vitamin D for-tifcation and supplementation. Scand J Clin Lab Invest Suppl. 2012;243:144-53.
94. Ross AC, Manson JE, Abrams SA, Aloia J F, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53-8.
95. Pinheiro MM, Schuch NJ, Genaro PS, Ciconelli RM, Ferraz MB, Martini LA. Nutrient intakes related to osteoporotic fractures in men and women--the Brazilian Osteoporosis Study (BRAZOS). Nutr J. 2009;8:6.
96. Autier P, Gandini S, Mullie P. A systematic review: influence of vitamin D supplementation on serum 25-hydroxyvitamin D concentration. J Clin Endocrinol Metab. 2012;97(8):2606-13.
97. Dawson-Hughes B, Harris SS, Palermo NJ, Ceglia L, Rasmussen H. Meal conditions affect the absorption of supplemental vitamin D3 but not the plasma 25-hydroxyvitamin D response to supplementation. J Bone Miner Res. 2013;28(8):1778-83.
98. Heaney R P, Davies KM, Chen TC, Holick M F, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003;77(1):204-210. Erratum in: Am J Clin Nutr. 2003;78(5):1047.
99. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999;69(5):842-56.
100. Holick M F, Wacker M. Vitamin-D effects on skeletal and ex-traskeletal health and the need of supplementation. Nutrients. 2013;5(1):111-48.
101. Tripkovic L, Lambert H, Hart K, Smith C P, Bucca G, Penson S, et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr. 2012;95(6):1357-64.
102. Houghton LA, Vieth R. The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr. 2006;84(4):694-7.
103. Logan V F, Gray AR, Peddie MC, Harper MJ, Houghton LA. Long-term vitamin D3 supplementation is more effective than vitamin D2 in maintaining serum 25-hydroxyvitamin D status over the winter months. Br J Nutr. 2013;109(6):1082-8.
104. Biancuzzo RM, Clarke N, Reitz RE, Travison TG, Holick M F. Serum concentrations of 1,25-dihydroxyvitamin D2 and 1,25-dihydro-xyvitamin D3 in response to vitamin D2 and vitamin D3 supplementation. J Clin Endocrinol Metab. 2013;98(3):973-9.
105. Thacher TD, Fischer PR, Obadofn MO, Levine MA, Singh RJ, Pettifor JM. Comparison of metabolism of vitamins D2 and D3 in children with nutritional rickets. J Bone Miner Res. 2010;25(9):1988-95.
106. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009;(113):S1-S130.
107. Metzger M, Houillier P, Gauci C, Haymann J P, Flamant M, Thervet E, et al.; NephroTest Study Group. Relation between circulating levels of 25(OH) vitamin D and parathyroid hormone in chronic kidney disease: quest for a threshold. J Clin Endocrinol Metab. 2013;98(7):2922-8.
108. London G, Coyne D, Hruska K, Malluche HH, Martin KJ. The new kidney disease: improving global outcomes (KDIGO) guidelines - expert clinical focus on bone and vascular calcifcation. Clin Ne-phrol. 2010;74(6):423-32.
109. Cuppari L, Garcia Lopes MG, Kamimura MA. Vitamin D biology: from the discovery to its signifcance in chronic kidney disease. J Ren Nutr. 2011;21(1):113-6.
110. Carvalho AB, Gueiros A P, Gueiros JE, Neves CL, Karohl C, Sam-paio E, et al. Guidelines on bone mineral disorder in chronic kidney disease--addendum chapter 2. J Bras Nefrol. 2012;34(2):199-205.
111. Lewiecki EM. Nonresponders to osteoporosis therapy. J Clin Den-sitom. 2003 Winter;6(4):307-14.
112. Adami S, Giannini S, Bianchi G, Sinigaglia L, Di Munno O, Fiore CE, et al. Vitamin D status and response to treatment in post-me-nopausal osteoporosis. Osteoporos Int. 2009;20(2):239-44.
113. Shab-Bidar S, Bours S P, Geusens P P, van der Velde RY, Janssen MJ, van den Bergh J P. Suboptimal effect of different vitamin D3 supplementations and doses adapted to baseline serum 25(OH)D on achieved 25(OH)D levels in patients with a recent fracture: a prospective observational study. Eur J Endocrinol. 2013;169(5):597-604.
114. Santos M T, Souza FI, Fonseca FL, Lazaretti-Castro M, Sarni RO. Changes in bone metabolism markers in women after Roux-en-Y gastric bypass. Arq Bras Endocrinol Metabol. 2012;56(6):376-82.
115. Viégas M, Vasconcelos RS, Neves A P, Diniz E T, Bandeira F. Baria-tric surgery and bone metabolism: a systematic review. Arq Bras Endocrinol Metabol. 2010;54(2):158-63.
116. Nakamura KM, Haglind EG, Clowes JA, Achenbach SJ, Atkinson EJ, Melton LJ 3rd, et al. Fracture risk following bariatric surgery: a population-based study. Osteoporos Int. 2014;25(1):151-8.
117. Censani M, Stein EM, Shane E, Oberfeld SE, McMahon DJ, Ler-ner S, et al. Vitamin D Deficiency Is Prevalent in Morbidly Obese Adolescents Prior to Bariatric Surgery. ISRN Obes. 2013;2013. pii: 284516.
118. Aghajafari F, Nagulesapillai T, Ronksley PE, Tough SC, O'Beirne M, Rabi DM. Association between maternal serum 25-hydro-xyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies. BMJ. 2013;346:f1169.
119. Thorne-Lyman A, Fawzi WW. Vitamin D during pregnancy and maternal, neonatal and infant health outcomes: a systematic review and meta-analysis. Paediatr Perinat Epidemiol. 2012;26 Suppl 1:75-90.
120. Cunningham J, Zehnder D. New vitamin D analogs and changing therapeutic paradigms. Kidney Int. 2011;79(7):702-7.
121. Coyne D, Acharya M, Qiu P, Abboud H, Batlle D, Rosansky S, et al. Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD. Am J Kidney Dis. 2006;47(2):263-76.
122. Zangeneh F, Clarke BL, Hurley DL, Watts NB, Miller PD. Chronic Kidney Disease Mineral and Bone Disorders (CKD-MBD) What the Endocrinologist Needs to Know. Endocr Pract. 2013;10:1-46.
123. Xu L, Wan X, Huang Z, Zeng F, Wei G, Fang D, et al. Impact of vitamin D on chronic kidney diseases in non-dialysis patients: a meta-analysis of randomized controlled trials. PLoS One. 2013;8(4):e61387.
124. Duranton F, Rodriguez-Ortiz ME, Duny Y, Rodriguez M, Daurès J P, Argilés A. Vitamin D treatment and mortality in chronic kidney disease: a systematic review and meta-analysis. Am J Nephrol. 2013;37(3):239-48.
125. Hagino H, Takano T, Fukunaga M, Shiraki M, Nakamura T, Matsu-moto T. Eldecalcitol reduces the risk of severe vertebral fractures and improves the health-related quality of life in patients with osteoporosis. J Bone Miner Metab. 2013;31(2):183-9.
126. Nakamura T, Takano T, Fukunaga M, Shiraki M, Matsumoto T. Elde-calcitol is more effective for the prevention of osteoporotic fractures than alfacalcidol. J Bone Miner Metab. 2013;31(4):417-22.
127. Tentori F, Hunt WC, Stidley CA, Rohrscheib MR, Bedrick EJ, Meyer KB, et al.; Medical Directors of Dialysis Clinic Inc. Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int. 2006;70(10):1858-65.
128. Bonakdaran S, Hami M, Hatef A. The effects of calcitriol on albu-minuria in patients with type-2 diabetes mellitus. Saudi J Kidney Dis Transpl. 2012;23(6):1215-20.
129. Jørgensen HS, Winther S, Povlsen JV, Ivarsen P. Effect of vitamin--D analogue on albuminuria in patients with non-dialysed chronic kidney disease stage 4-5: a retrospective single center study. BMC Nephrol. 2012;13:102.
130. Looker AC. Serum 25-hydroxyvitamin D and risk of major os-teoporotic fractures in older U.S. adults. J Bone Miner Res. 2013;28(5):997-1006.
131. Noguchi Y, Kawate H, Nomura M, Takayanagi R. Eldecalcitol for the treatment of osteoporosis. Clin Interv Aging. 2013;8:1313-21.
132. Christakos S, DeLuca H. Minireview: vitamin D: is there a role in extraskeletal health? Endocrinology. 2011;152(8):2930-6.
133. Nagpal S, Na S, Rathachalam R. Non calcemic actions of vitamina D receptor ligands. Endocr Rev. 2005;26(5):662-87.
134. Visweswaran R, Lekha H. Extraskeletal effects and manifestations of Vitamin D deficiency. Indian J Endocrinol Metab. 2013;17(4):602-10.
135. Holick M F. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers and cardiovascular disease. Am J Clin Nutr. 2004;80(6 Suppl):1678S-88S.
136. Elamin MB, Abu Elnour NO, Elamin KB, Fatourechi MM, Alkatib AA, Almandoz J P, et al. Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2011;96(7):1931-42.
137. Fiscella K, Franker P. Vitamin D, race and cardiovascular mortality with fndings from a national US sample. Ann Fam Med. 2010;8(1):11-8.
138. Pilz S, März W, Wellnitz B, Seelhorst U, Fahrleitner-Pammer A, Dimai H P, et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab. 2008;93(10):3927-35.
139. Rajasree S, Rajpal K, Kartha CC, Sarma PS, Kutty VR, Iyer CS, et al. Serum 25-hydroxivitamin D3 levels are elevated in South Indian patients with ischemic heart disease. Eur J Epidemiol. 2001;17(6):567-71.
140. Christakos S, Hewison M, Gardner DG, Wagner CL, Sergeev IN, Rutten E, et al. Vitamin D: beyond bone. Ann N Y Acad Sci. 2013;1287:45-58.
141. Motiwala SR, Wang TJ. Vitamin D and cardiovascular disease. Curr Opin Nephrol Hypertens. 2011;20(4):345-353.
142. Pittas AG, Harris SS, Stark PC, Dawson Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of infammation in nondiabetic adults. Diabetes Care. 2007;30(4):980-6.
143. Danescu LG, Levy S, Levy J. Vitamin D and diabetes mellitus. Endocrine. 2009;35(1):11-7.
144. Vitamin D supplement in early childhood and risk for Type 1 (insulin-dependent) diabetes mellitus. The EURODIAB Substudy 2 Study Group. Diabetologia. 1999;42(1):51-4.
145. Zipitis CS, Akobeng Ak. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta--analysis. Arch Dis Child. 2008;93(6):512-7.
146. Pittas AG, Lau J, Hu B, Dawson Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta--analysis. J Clin Endocrinol Metab. 2007;92(6):2017-29.
147. Song Y, Wang L, Pittas AG, Del Gobbo LC, Zhang C, Manson JE, et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care. 2013;36(5):1422-8.
148. de Boer IH, Tinker L F, Connelly S, Curb JD, Howard BV, Kesten-baum B, et al.; Women's Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care. 2008;31(4):701-7.
149. 3 (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer. Endocrinology. 2012;153(6):2576-2587.
150. Krishnan AV, Feldman D. Mechanisms of the anti-cancer and anti--infammatory actions of vitamin D. Annu Rev Pharmacol Toxicol. 2011;51:311-36.
151. Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol. 2014;2:76-89.
152. Pike JW. Genome-wide principles of gene regulation by the vitamin D receptor and its activating ligand Mol Cell Endocrinol. 2011;347(1-2):3-10.
153. Leyssens C, Verlinden L, Verstuyf A. Antineoplastic effects of 1,25(OH)2D3 and its analogs in breast, prostate and colorectal cancer. Endocr Relat Cancer. 2013;20(2):R31-47.
154. Tanaka H, Abe E, Miyaura C, Kuribayashi T, Konno K, Nishii Y, et al. 1 alpha,25-dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60). Biochem J. 1982;204(3):713-9.
155. Holick M F. Vitamin D: A millennium perspective. J Cell Biochem. 2003;88(2):296-307.
156. Holick M F. Vitamin D: extraskeletal health. Endocrinol Metab Clin North Am. 2010;39(2):381-400, table of contents.
157. Hewison M, Freeman L, Hughes SV, Evans KN, Bland R, Eliopoulos AG, et al. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol. 2003;170(11):5382-90.
158. Jeffery LE, Wood AM, Qureshi OS, Hou TZ, Gardner D, Briggs Z, et al. Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and infammatory T cell responses. J Immunol. 2012;189(11):5155-64.
159. Hewison M. Antibacterial effects of vitamin D. Nat Rev Endocri-nol. 2011;7(6):337-45.
160. Salahuddin N, Ali F, Hasan Z, Rao N, Aqeel M, Mahmood F. Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis'. BMC Infect Dis. 2013;13:22.
161. Holick M F, Chen ML, Kong X F, Sanan DK. Clinical uses for cal-ciotropic hormones 1,25-dihydroxyvitamin D3 and parathyroid hormone-related peptide in dermatology: a new perspective. J Investig Dermatol Symp Proc. 1996;1(1):1-9.
162. Brown SD, Calvert HH, Fitzpatrick AM. Vitamin D and asthma. Dermatoendocrinol. 2012;4(2):137-145.
163. Searing DA, Zhang Y, Murphy JR, Hauk PJ, Goleva E, Leung DY. Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use. J Allergy Clin Immunol. 2010;125(5):995-1000.
164. Gallagher JC. The effects of calcitriol on falls and fractures and physical performance tests. J Steroid Biochem Mol Biol. 2004;89-90(1-5):497-501.
165. Llewellyn DJ, Lang IA, Langa KM, Muniz-Terrera G, Phillips CL, Cherubini A, et al. Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med. 2010;170(13):1135-41.
166. Song Q, Sergeev IN. Calcium and vitamin D in obesity. Nutr Res Rev. 2012;25(1):130-41.